跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DAPAGLIFLOZINA/METFORMINA AUROVITAS 5 MG/1 000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DAPAGLIFLOZINA/METFORMINA AUROVITAS 5 MG/1 000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
DAPAGLIFLOZINA/METFORMINA AUROVITAS 5 MG/1 000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Aurovitas Spain, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 5, 2026
Approval ID
4eb9f9e3577d1c62
Company
Aurovitas Spain, S.A.U.
Type
Standard
Approval Details
Approval Id
4eb9f9e3577d1c62
Drug Cima Aemps Name
DAPAGLIFLOZINA/METFORMINA AUROVITAS 5 MG/1 000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
91231
Holder Company Name
Aurovitas Spain, S.A.U.
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2026-06-05
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 mg/1000 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Aurovitas Spain, S.A.U.
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 5, 2026
Approval ID
4eb9f9e3577d1c62
Type
Standard
Back to CIMA-AEMPS Approvals